Lexicon Pharmaceuticals, Inc.【LXRX】 業績推移・財務諸表

機能の使い方
(単位:%) 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 1Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 555 355 343 300 199 372 218 360 214 238 1,410 277 676 419 21,482 1,792 376 566 127,280 12,494 20,089 27,717 18,293 12,053 26,942 33,047 25,207 13,753 6,856 17,071 9,216 9,682 294,448 8,727 7,999 9,163 6,634 23,962 27 234 23 14 - - - - - 317 162 608 1,130 1,647 1,750 26,630 1,262 28,866 14,182 5,493
売上成長率(%) - - - - - - - - - - - - - - - 4279.9 11.7 1652.6 710.4 -79.4
売上原価 - - - - - - - - - - - - - - - - - - - - - - 225 537 599 538 533 838 551 569 553 1,327 577 774 568 728 633 0 - - - - - - - - - 8 7 70 31 166 71 348 30 33 10 201
研究開発費 20,145 19,655 28,107 23,037 19,355 19,192 20,990 20,327 23,692 25,400 20,263 23,953 21,187 24,108 20,031 20,865 20,769 23,111 30,442 37,002 48,216 52,533 43,581 26,934 39,137 47,160 47,783 26,589 13,769 12,102 12,022 12,637 26,659 40,606 55,181 57,301 40,147 992 12,609 10,257 15,682 16,498 14,926 13,356 10,557 13,977 12,026 14,541 17,558 14,762 14,372 17,643 25,780 26,685 15,303 15,747 18,757 11,315
販売管理費 - - - - - - - - - - - - - - - - - - - - - - 14,871 18,475 16,724 - 14,857 - - - - - - - - - - - - - - - - - - - - - 32,228 32,607 32,060 39,192 39,592 32,258 11,608 9,350 7,602 8,757
営業費用 26,481 26,046 33,685 29,683 25,679 29,432 24,710 25,915 28,838 31,454 18,386 30,749 26,787 40,755 24,929 28,319 27,064 34,243 38,920 46,365 57,110 62,650 60,778 45,946 56,460 63,832 63,173 44,182 29,899 29,234 26,685 28,227 69,772 55,944 70,437 73,742 52,777 7,424 20,866 18,193 22,985 25,344 23,417 -24,042 -23,134 30,306 -31,166 44,557 49,793 47,439 46,463 57,001 65,443 59,291 26,941 25,130 26,369 20,273
営業利益 -25,926 -25,691 -33,342 -29,383 -25,480 -29,060 -24,492 -25,555 -28,624 -31,216 -16,976 -30,472 -26,111 -40,336 -3,447 -26,527 -26,688 -33,677 88,360 -33,871 -37,021 -34,933 -42,485 -33,893 -29,518 -30,785 -37,966 -30,429 -23,043 -12,367 -17,469 -18,545 224,676 -47,217 -62,438 -64,579 86,675 -7,458 -20,839 -17,959 -22,962 -25,330 -23,380 -24,007 -23,095 -30,278 -31,142 -44,240 -49,631 -46,737 -45,333 -55,354 -63,693 -32,737 -25,679 3,736 -12,187 -14,780
営業利益率 (%) - - - - - -122.9 -2034.8 12.9 -85.9 -269.1
経常(税引前)利益 - -26,103 -33,845 - - - - - - - - - - - - - - - - - - - -43,543 -35,059 -30,722 -32,387 -42,075 -34,706 -27,512 -16,255 - - 220,072 -51,138 - - 82,603 -5,495 - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益率(%) - -7353.0 -9867.3 - - - - - - - - - - - - - - - - - - - -238.0 -290.9 -114.0 -98.0 -166.9 -252.4 -401.3 -95.2 - - 74.7 -586.0 - - 1245.1 -22.9 - - - - - - - - - - - - - - - - - - - -
法人税等合計 - 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -26,638 -26,103 -33,845 -29,868 -25,931 -29,539 -24,873 -25,974 -29,080 -31,658 -17,414 -30,835 -26,028 -40,498 -2,933 -28,076 -28,074 -35,282 86,750 -34,883 -38,112 -36,015 -34,891 -35,059 -30,722 -28,378 -42,075 -34,706 -27,512 -16,781 -21,797 -23,018 226,086 -51,138 -66,611 -69,071 82,603 -5,495 -20,958 -18,067 -23,122 -25,611 -23,476 -24,587 -23,387 -30,494 -31,934 -44,904 -50,525 -49,756 -48,397 -53,429 -64,811 -33,766 -25,295 3,252 -12,769 -15,530
純利益率(%) - - - - - -126.8 -2004.4 11.3 -90.0 -282.7
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 2.13 -0.48 -0.63 -0.65 0.77 -0.03 -0.15 -0.13 -0.16 -0.17 -0.16 -0.16 -0.13 -0.17 -0.17 -0.22 -0.21 -0.2 -0.2 -0.17 -0.18 -0.09 -0.07 0.01 -0.04 -0.04
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.95 -0.48 -0.63 -0.65 0.71 -0.03 -0.15 -0.13 -0.16 -0.17 -0.16 -0.16 -0.13 -0.17 -0.17 -0.22 -0.21 -0.2 -0.2 -0.17 -0.18 -0.09 -0.07 0.01 -0.04 -0.04
EBITDA - - - -32,612 -25,503 3,912 -12,036 -14,662
EBITDAマージン(%) - - - - - - - - -122.5 -2020.8 13.6 -84.9 -266.9